Perrigo Company (NASDAQ:PRGO)
| CAPS Rating |
|
|---|---|
| Open | $93.47 |
| Previous Close | $94.05 |
| Daily Range | $92.60 - $93.47 |
| 52-Week Range | $70.94 - $104.70 |
| Market Cap | $8.66B |
| P/E Ratio | 27.10 |
| Dividend (Yield) | 0.32 (0.50%) |
| Volume | 627,047 |
| Average Daily Volume | 0 |
PRGO
VS S&P 500 (SPY)
How do you think PRGO will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
PRGO Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
PRGO News and Commentary
- Perrigo Increases Sales but Misses Estimates on Earnings – The Motley Fool
- Perrigo Beats EPS, Top Line Solid - Analyst Blog – NASDAQ
- Perrigo Earnings Preview – The Motley Fool
- Perrigo's Growth May Not Be What It Seems – The Motley Fool
- Perrigo Files for Generic Astepro - Analyst Blog – NASDAQ
- Sorry Barron's, There is Nothing Magical About 4% – Blogs @ The Motley Fool
- Could Perrigo Be Hiding Weakness? – The Motley Fool
- Investing In Israel – Blogs @ The Motley Fool
- Buy This Parabolic Stock – Blogs @ The Motley Fool
- Perrigo Cleared for Generic Mucinex - Analyst Blog – NASDAQ
- Perrigo: US Court Finds Generic Mucinex Doesn't Infringe Patents – SmartMoney
- Perrigo Down to Neutral - Analyst Blog – NASDAQ
- Is Perrigo the Perfect Stock for 2012? – The Motley Fool
- Hansen, GOLD Among Nasdaq 100's Most Oversold Stocks – NASDAQ
- Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo - P – NASDAQ
- You Probably Just Bought These Stocks – The Motley Fool
- 1 Reason Perrigo May Be Headed for a Slowdown – The Motley Fool
- These Companies Will Make Big Moves This Friday – The Motley Fool
- Should You Buy the Nasdaq's Forgotten Stocks? – The Motley Fool
- 4 Investments That Everybody Loves – The Motley Fool
RSS Headlines
Fool UK
